Positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose in oncology: Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and …
MPM Stokkel, A Draisma, EKJ Pauwels - Journal of cancer research and …, 2001 - Springer
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) is considered to
be a very useful adjunct to anatomic imaging techniques and is now primarily used for …
be a very useful adjunct to anatomic imaging techniques and is now primarily used for …
PET/CT “Cometh the hour, cometh the machine?”
JC Clarke - Clinical radiology, 2004 - clinicalradiologyonline.net
Clinical positron emission tomography (PET) and PET/computed tomgraphy (CT) are rapidly
expanding and there are many plans for new installations in the UK. This is because PET …
expanding and there are many plans for new installations in the UK. This is because PET …
Molecular Imaging in Early Therapy Monitoring
S Klutmann, A Stahl - Cancer Imaging, 2008 - Elsevier
Publisher Summary This chapter presents the roles of 2-[18F] fluoro-2-deoxy-D-glucose (F-
18-FDG) and positron emission tomography (PET) in cancer imaging. Tumor uptake of FDG …
18-FDG) and positron emission tomography (PET) in cancer imaging. Tumor uptake of FDG …
Non-FDG PET in the practice of oncology.
P Caroli, C Nanni, D Rubello, A Alavi… - Indian journal of …, 2010 - search.ebscohost.com
Abstract Fluoro–2–deoxy–d–glucose–positron emission tomography (FDG–PET) is utilized
in more than 90% of cancers in staging, re–staging, assessing therapy response and during …
in more than 90% of cancers in staging, re–staging, assessing therapy response and during …
PET FDG studies in oncology
RA Hawkins, CK Hoh - Nuclear medicine and biology, 1994 - Elsevier
Positron emission tomography (PET) studies of cancer with the glucose analog 2-[F-18]
fluoro-2-deoxy-d-glucose (FDG) have emerged as both a useful research and clinical …
fluoro-2-deoxy-d-glucose (FDG) have emerged as both a useful research and clinical …
[PDF][PDF] Clinical applications of PET in lung cancer
CYO Wong, WS Huang, CY Cheng - Ann Nucl Med Sci, 2004 - researchgate.net
Lung cancer is responsible for 32% of all cancer deaths in men and 25% in women in the
United States. It also ranked first in women (17.3%) and ranked second in men (23.2%) of …
United States. It also ranked first in women (17.3%) and ranked second in men (23.2%) of …
PET Metabolic Biomarkers for Cancer: Supplementary Issue: Biomarkers and their Essential Role in the Development of Personalised Therapies (A)
E Croteau, JM Renaud, MA Richard… - Biomarkers in …, 2016 - journals.sagepub.com
The body's main fuel sources are fats, carbohydrates (glucose), proteins, and ketone bodies.
It is well known that an important hallmark of cancer cells is the overconsumption of glucose …
It is well known that an important hallmark of cancer cells is the overconsumption of glucose …
Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors
E Panagiotidis, J Bomanji - PET clinics, 2014 - pet.theclinics.com
Two of the most significant recent advances in medical imaging have been the introduction
of Positron Emission Tomography (PET) and of the glucose analogue fluorodeoxyglucose …
of Positron Emission Tomography (PET) and of the glucose analogue fluorodeoxyglucose …